The Medicare reimbursement landscape for next-generation sequencing and other molecular diagnostics remain murky, labs and test makers say, following CMS' recent publication of its proposed 2015 clinical laboratory fee schedule test codes and preliminary payment determinations.
At the end of May, the agency published an excel
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?